Sonoma Pharmaceuticals, Inc. (SNOA)
$1.34+0.00%Close
BUYRECOVERY · day 49
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $2M
- Avg volume
- 224.7K
- Beta
- 1.29
- P/E (TTM)
- -1.10
- Short % float
- 0.50%
- Days to cover
- 1.0
- SI change
- -83.0%
- 1W
- +1.52%
- 1M
- +17.54%
- 3M
- +21.82%
- YTD
- -63.19%
- vs SPY 1W
- +2.71%
- vs SPY 1M
- +14.22%
- vs SPY 3M
- +19.43%
- vs SPY YTD
- -74.94%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ANEBBUYAnebulo Pharmaceuticals, Inc.CRISISQ -4$0.31-6.06%
- BBLGSELLBone Biologics CorporationCRISISQ -23$0.61-3.17%
- UEECSELLUnited Health Products, Inc.CRISISQ 8$0.04+0.00%
- MASSBUY908 Devices Inc.BULLQ 1$10.92+2.25%
- OMSELLOutset Medical, Inc.CRISISQ -34$4.19-0.48%
- EXOZBUYeXoZymes, Inc.RECOVERYQ 0$6.95-2.80%
- MXCTBUYMaxCyte, Inc.RECOVERYQ 13$1.39+0.72%
- RYTMBUYRhythm Pharmaceuticals, Inc.BEARQ 22$111.44+1.31%
- SEPNBUYSepterna, Inc.CRISISQ 29$40.52+1.30%
- ATECBUYAlphatec Holdings, Inc.RECOVERYQ -1$9.24-2.53%
- HKPDSELLCellyan Biotechnology Co., LtdCRISISQ -24$0.37-9.76%
- MYGNSELLMyriad Genetics, Inc.CRISISQ 5$3.05-4.69%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 12
- VALUE
- 13
- GROWTH
- 44
- GARP
- 8
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-27.6%
REV YoY-
ROE-23.9%
EPS YoY-
ROA-12.5%
GROSS39
OP-6
NET-10
[VALUATION]
P/E TTM-1.10
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.61
P/B0.78
P/FCF-
EV/EBITDA1.47
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E11.21
ALTMAN Z-
CURR RATIO2.99
ND/EBITDA-
BETA1.29
NET INCOME (TTM) < 0
